Pfizer (NYSE:PFE)

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

After Apple Inc. (NASDAQ: AAPL) announced that it would contribute $350 billion to the U.S. economy, there has been at least some attention to how it gets there. The reality ...
Read Full Story »

Major Pharma Short Interest Takes a Plunge

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

UnitedHealth, Disney Weigh on DJIA Monday

January 8, 2018: Markets opened mixed Monday after remarks by some Fed officials that interest rates could get more than three raises next year as the economy grows. New tax ...
Read Full Story »

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

Now that 2017 has come and gone, this raging bull market is now nearing nine years old. It is also the strongest bull market that most investors have seen in ...
Read Full Story »

Sangamo Jumps on Newest Pfizer Collaboration

Sangamo Therapeutics Inc. (NASDAQ: SGMO) shares made a handy gain on hump day after the firm announced that it would be collaborating with pharma giant Pfizer Inc. (NYSE: PFE) for ...
Read Full Story »

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

It is no secret as 2018 kicks into gear that stocks are in the midst of a raging bull market. In fact, this bull market will turn nine years old ...
Read Full Story »

More and More Short Sellers Raising the Stakes in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Meet the Preliminary Dogs of the Dow for 2018

It is no secret that the bull market's strength heading into 2018 is nearing uncharted territory. Wall Street strategists have recently raised their 2018 stock market expectations after the passage ...
Read Full Story »

Disney, General Electric Hobble DJIA on Wednesday

December 20, 2017: Markets opened higher Wednesday but spent most of the day within inches of the break-even line. Maybe a case of "sell the news" now that the Republican ...
Read Full Story »

Tax Reform Stocking Stuffer: Pfizer Dividend Hike & Much Larger Stock Buyback

It is no secret that investors love stock buyback and dividend announcements. Within reason, companies raising dividends and increasing buybacks are particularly loved. Pfizer Inc. (NYSE: PFE) wants its part ...
Read Full Story »

Intel, Microsoft Dominate DJIA Friday

December 15, 2017: Markets opened higher again Friday and continue to put up gains throughout the day. All three major equities indexes posted new intra-day highs as all sectors traded ...
Read Full Story »

Pfizer Headed for New High After FDA Nod for Joint Disease Treatment

Shares of Pfizer Inc. (NYSE: PFE) rose about 1.3% in afterhours trading Thursday after the company announced that the U.S. Food and Drug Administration (FDA) had approved Xeljanz (tofacitinib) for ...
Read Full Story »

Why Cellectis Is Winning Big With Its Pfizer Partnership

Shares of Cellectis S.A. (NASDAQ: CLLS) saw a handy gain early on Wednesday after the firm announced preliminary data from its two Phase 1 studies in conjunction with Pfizer Inc. ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Disney, Apple Pace Dow to Monday Gain

December 11, 2017: Markets opened mixed Monday with the DJIA lagging a bit. By mid-afternoon all three major indexes were trading in the green, even if barely. Tech, telecom, and ...
Read Full Story »